A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR)
NCT ID: NCT04010214
Last Updated: 2023-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2019-07-01
2059-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
NCT02488031
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
NCT01060371
The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar Ataxia
NCT06904716
The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia
NCT01983631
Biomarker Research in Inherited Movement Disorders
NCT05034172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Relatives of patients with cerebellar ataxia
* Unrelated healthy controls
* Participants or legal guardian(s) willing and able to complete the informed consent process
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ning Wang, MD., PhD.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ning Wang, MD., PhD.
The Vice President
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology ,First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRCTA,ECFAH of FMU[2019]195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.